Italian Diagnostic Shop Distributing Transgenomic's Mutation Detection System in Europe | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Italian firm A. Menarini Diagnostics will exclusively distribute Transgenomic's Surveyor Scan and Wave Micro-capillary electrophoresis (MCE) mutation detection system throughout Europe as part of a deal announced today.

Under the terms of the deal, Menarini, based in Florence, Italy, will make the Transgenomic technology available to the more than 2,000 pathologists in its European network. Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.